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ABSTRACT 
 
Small RNA-mediated gene silencing is an ancient, evolutionarily conserved and only 
recently discovered gene regulatory mechanism. This thesis is aimed towards 
understanding the function of small RNA pathways in the model organism Caenorhabditis 
elegans, and furthermore to understand their role in neurodegenerative diseases. In order 
to study small RNA pathways and their potential therapeutic applications in neurological 
diseases, molecular genetic, RNA interference, microarray, and in silico techniques were 
used as an experimental approach.                  
         Firstly, different neuron types were examined for their sensitivity to exogenously 
delivered small interfering RNAs (exo-siRNAs). The sensitivity was found to vary between 
different neuron types and dysfunctional RRF-3 protein was shown to increase the 
effectiveness in all measured cell types. Secondly, using an rrf-3 mutant animal, candidate 
targets of endogenous small interfering RNAs (endo-siRNAs) were identified and their 
functions were found to be enriched in regulating genes involved in protein 
phosphorylation, embryonic development, and sperm motility. Thirdly, endogenous siRNAs 
previously identified by high-throughput sequencing were distributed by size and found to 
have size-specific functions. Finally, expression levels of microRNAs in several C. elegans 
models of Parkinson’s disease were measured and two differentially regulated microRNA 
families were identified as potentially involved in Parkinson’s disease-associated 
pathogenic mechanisms. 
         In conclusion, the effectiveness and functions of exogenous and endogenous small 
RNAs were studied in order to provide a more thorough understanding of their biology with 
the prospect of using this information in development of small RNA-based therapies for 
neurodegenerative diseases. 
 
 
 
Universal Decimal Classification: 575.113, 577.113, 577.218, 595.132 
National Library of Medicine Classification: QU 475, QX 203, WL 359, QY 58 
Medical Subject Headings: Gene Expression Regulation; Gene Silencing; RNA, Small 
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Analysis; Neurons; Phosphorylation; Proteins; Embryonic Development; Sperm Motility; 
Neurodegenerative Diseases/therapy; Parkinson Disease; Disease Models, Animal 
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1 INTRODUCTION  
 
The gene silencing process, which is at least a billion years old, is constantly operating in 
virtually all cells of eukaryotic organisms, including human, and is mediated by a number 
of small RNA classes derived from precursor molecules with diverse origin. This ancient 
molecular mechanism, collectively termed RNA interference (RNAi), has given birth to a 
range of pathways able to protect organisms from mobile genetic elements such as viral 
genomes and transposons, and regulate gene expression that is essential for animal 
development and health. RNAi is triggered by cellular invasion of exogenous double-
stranded RNA (dsRNA), or a variety of endogenous precursor RNAs transcribed from the 
genome, with the ability to silence genes with a corresponding sequence either via 
interacting with the messenger RNAs (mRNAs), or proteins able to alter chromatin 
structure in the target locus. 
The division between specialized RNAi pathways is typically distinguished by the 
molecular properties of mature, processed small RNA, that have an ability to guide “RNAi 
effector enzyme complexes” in proximity of the target RNA. In somatic cells of all animals, 
highly conserved microRNAs (miRNAs) are the most abundant class of endogenous small 
RNAs with gene targets in a wide range of cellular processes. In addition to miRNAs, a 
species of genome encoded endogenous siRNAs (endo-siRNAs) regulate genes and 
transposable elements. However, while a large number of endo-siRNAs have been 
characterized in somatic cells of Caenorhabditis elegans (C. elegans) and Drosophila 
melanogaster (D. melanogaster), there is limited evidence for the existence of endo-
siRNAs in mammalian soma. Thus, endo-siRNA mediated gene regulation may 
predominate in the germline in mammals. To add more complexity to small RNA 
pathways, long, exogenous dsRNA is able to activate production of endo-siRNA-like 
molecules referred to as exogenous siRNAs (exo-siRNAs). The exo-siRNA-specific 
pathway is able to silence virtually any endogenous gene with corresponding sequence in 
any tissue, and not surprisingly, biotechnology efforts have exploited it as a knock-down 
method for gene expression. For the same reason, the pathway holds a large therapeutic 
potential against many severe diseases. Despite numerous research efforts, an 
endogenous function has not yet been reported for the mammalian exo-siRNA pathway 
suggesting that it might be a remnant from the past. Furthermore, animal germ cells and a 
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few germ cell associated tissues have shown to harbour the bulk of small RNAs referred to 
as Piwi-interacting RNAs (piRNAs; called also as Piwi-associated RNAs) which regulate 
expression of genes and transposons. As a general property, the miRNA pathway is 
dedicated to regulate gene expression in all tissues, while endo-siRNA and piRNA 
pathways add an additional layer of regulation to these genes in germ cells. Future studies 
will definitely add knowledge to the complexity of these pathways. 
In this thesis, classical molecular biology-, RNAi-, microarray-, and in silico techniques 
were used to study different RNAi pathways using the model organism C. elegans to 
understand their endogenous roles and to provide insight into their therapeutic potential. 
Neuronal approaches were taken when possible due to the paucity of knowledge of their 
functions in neurons. Different neuron types were observed to represent different levels of 
sensitivity to exo-siRNA pathway mediated silencing of a Green Fluorescent Protein 
(GFP)-transgene, and loss of RNA-dependent RNA polymerase (RRF-3) function was 
observed to sensitize all examined neuron types to silencing (Publication I). Candidate 
endo-siRNAs and their putative targets were characterized (Publications II and III). 
Furthermore, two miRNA families were found to be differentially expressed in C. elegans 
models of human Parkinson’s disease suggesting their involvement in molecular 
mechanisms associated with pathology in Parkinson’s disease (Publication IV).  
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2 REVIEW OF THE LITERATURE 
 
2.1 Finding gene silencing by small RNAs 
 
Gene silencing by RNA molecules were uncovered when attempts to over-express the 
chalcone synthase gene, to increase the flower pigment, resulted in a surprising block in 
its synthesis (Napoli et al., 1990; Van der Krol et al., 1990). In the mid-1990s, the 
discovery that plant viruses could also induce sequence-specific gene silencing seemed to 
be related to the silencing by the transgene. The link between two silencing pathways led 
to the suggestion that RNA, for example in double stranded form, might trigger the 
silencing (Ratcliff et al., 1997). Nine months later, Andrew Fire and Craig Mello with their 
co-workers proved this to be true in C. elegans and the phenomenon was named as RNA 
interference (RNAi) (Fire et al., 1998). In 2006, Andy Fire and Craig Mello received The 
Nobel Prize of Medicine for their discovery. The revelation that dsRNA induces effective 
gene silencing provided a way to "knock-down" mRNAs of any gene in virtually any 
organism thus revolutionizing the research methods of molecular biology.  
The fact that small RNAs may regulate genes in a sequence-specific and post-
transcriptional manner was actually reported already in the beginning of 1990s when the 
laboratory of Victor Ambros reported their finding of an antisense small RNA called lin-4, 
which was complementary to a sequence element in the 3’UTR of lin-14 mRNA (Lee et al., 
1993). Later, lin-4 was reported to belong to the miRNA species (Lau et al., 2001). 
Furthermore, Andrew Hamilton and David Baulcombe demonstrated how antisense small 
RNAs were able to target mRNAs for gene silencing in plants (Hamilton and Baulcombe, 
1999). In 2008, Ambros and Baulcombe received The Albert Lasker Award together with 
Gary Ruvkun, who had reported the finding of let-7 (Reinhart et al., 2000). Only recently, 
the discovery of novel endogenous small RNA species has been accelerated along with 
the development of new high-throughput sequencing technologies. Taken together, these 
discoveries have revealed an ancient cellular mechanism which has had enormous 
contributions in evolution of plants and animals. 
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2.2 Evolution and functions of small RNAs 
 
Computational genomic studies have suggested that the first form of a RNAi mechanism 
was present already in the last common ancestor of modern eukaryotes about two billion 
years ago and much evidence suggests that its early function was  to protect against 
viruses via the exo-siRNA-like pathway (Cerrutti et al., 2006; Shabalina and Kooning, 
2008; Obbard et al., 2009). The observation that the primitive RNAi machinery contained 
at least three conserved RNAi pathway enzymes: a RNAse III endonuclease Dicer, an 
Argonaute family of small RNA binding enzyme (AGO), and a RNA-dependent RNA 
polymerase (RdRP), suggests that the primitive RNAi mechanism may have been capable 
of small RNA-guided mRNA degradation and transcriptional repression through 
heterochromatin formation (Cerutti et al., 2006). The machinery seems to have been 
assembled from prokaryotic proteins involved in DNA-repair and RNA-processing 
pathways unrelated to RNAi, which points towards an independent origin of RNAi in 
eukaryotes (Anantharaman et al., 2002; MacRae and Doudna, 2007). The evolution of the 
first genome encoded siRNA (endo-siRNA) and microRNA (miRNA) genes and their 
associated pathways likely followed after the exo-siRNA pathway. Dramatic expansion of 
endogenous small RNA genes during two periods of eukaryotic evolution strongly suggest 
that their gene regulation facilitated the evolution of more complex and diverse organs and 
body plans (Hertel et al., 2006; Prochnik et al., 2007). The first burst took place during the 
birth of the first bilateria with clear body structures characterized by head, tail, back and 
abdomen. The birth of miRNA pathway likely fell into this period. Another expansion in 
miRNA numbers happened in ancestors of vertebrates.  
In many modern eukaryotes, the exo-siRNA-mediated antiviral defence remains 
functional although its role in vertebrates is controversial (Ding and Voinnet 2007; 
Dougherty et al., 1994; Ruiz et al., 1998; Schott et al., 2005). More importantly, 
microRNAs, endo-siRNAs and piRNAs fine tune complex networks of endogenous gene 
expression establishing the development and maintenance of the physiological complexity 
of an animal. To understand the gene silencing phenomena in modern organisms, it is 
useful to review different small RNA mediated RNAi pathways and their roles in gene 
regulation. We have used the nematode C. elegans to model these mechanisms. 
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2.3 Small RNA pathways in C. elegans 
 
Studies using C. elegans have revealed four main RNAi pathways triggered by small 
RNAs able to regulate gene expression: miRNA, endo-siRNA, exo-siRNA, and recently 
reported piRNA (21U-RNA) pathways (Lee et al., 2006; Duchaine et al., 2006; Yigit et al., 
2006; Ruby et al., 2006; Batista et al., 2008; Aravin et al., 2007; Ghildiyal and Zamore, 
2009). An extensive amount of recent effort dissecting these pathways has revealed that 
they form a complex array of cell-specific variations and associate with various biological 
processes. These include mechanisms that silence endogenous genes (Ambros et al., 
2003; Lim et al., 2003), restrain the expression of selfish or exogenous genetic material 
(Dernburg et al., 2000; Robert et al., 2005), and direct transcriptional gene silencing via 
heterochromatin formation (Grishok et al., 2005; Grishok et al., 2008; Djupedal and Ekwall, 
2009). Activation of a specific silencing pathway seems to depend on the physiological 
nature of the precursor RNA, and on functions of mature small RNA associated specific 
AGOs (Yigit et al., 2006; Steiner et al., 2007; Steiner and Plasterk, 2006). To maintain a 
delicate balance in overlapping gene regulation processes, pathways have been shown to 
compete with common, rate limiting enzymes like Dicer and AGOs (Figure 1, Figure 2, 
Table 1).  
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Figure 1. A simplified model of the miRNA pathway in C. elegans.  
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Figure 2. A simplified model of the siRNA pathways in C. elegans.  
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Table 1. A list of specific events and enzymes involved in C. elegans small RNA pathways 
Small RNA 
pathway 
Origin of 
precursor 
Transport Dicer Argonautes Effect Reference
microRNA miRNA gene, 
intron 
from nucleus into 
cytoplasm by 
Exportin 5 
yes ALG-1, ALG-2 translation block, 
sometimes mRNA 
degradation 
Ambros et al., 2003 
endo-siRNA bidirectional 
transcript? 
not known yes RDE-1, ERGO-1, 
ERGO-2, SAGO-1, 
SAGO-2, CSR-1 
mRNA degradation Ambros et al., 2003; 
Yigit et al., 2006 
exo-siRNA long dsRNA from extracellular 
matrix into 
cytoplasm by 
SID-1 
yes RDE-4, RDE-1, 
SAGO-1, SAGO-2 
mRNA degradation, 
sometimes translation 
block 
Fire et al., 1998 
piRNA      
(21U-RNA) 
not known not known not 
known 
PRG-1 not known Ruby et al., 2006; 
Batista et al,.2008 
 
 
2.3.1 MicroRNAs 
 
Comparative genomics analyses suggest that the highly conserved miRNAs evolved in 
ancestors of bilateral organisms (Hertel et al., 2006; Prochnik et al., 2007). During 
evolution of the first vertebrates, their number increased dramatically making miRNAs 
good candidates for facilitating evolution of organism complexity. The existence of about 
150 miRNAs has been confirmed in C. elegans (Griffiths-Jones et al., 2008). A simplified 
model of the miRNA pathway is shown in Figure 1. 
 
2.3.1.1 Precursor molecules 
 
The first precursor of mature miRNA is transcribed by the RNA polymerase II from protein 
non-coding areas (Ambros et al., 2003; Lee et al., 2004). miRNA expression is often 
dynamically regulated, consistent with the role of these genes in cell fate determination 
and developmental timing (Lee et al., 1993; Reinhart et al., 2000; Plasterk et al., 2006). 
Genomes of all animals encode a number of genes dedicated to miRNA production, and in 
many cases, the multicistronic gene encodes several miRNAs (Ambros et al., 2003). As an 
exception, some miRNAs are derived from intronic sequences called mirtrons and 
therefore are able to bypass processing by RNAse III endonuclease Drosha, forming an 
alternative pathway for miRNA biogenesis (Figure 1; Table 1; Ambros et al., 2003; Ruby et 
al., 2007).  
         Traditionally, the initial miRNA precursor is several hundred nucleotides (nt) in length 
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and able to form complex secondary structures referred to as primary miRNA (pri-miRNA). 
Pri-miRNA is processed by Drosha and its co-factor Pasha to form miRNA precursor of 
~70nt in length called pre-miRNA (Lee et al., 2003; Denli et al., 2004; Carmell and Hannon 
2004). The conserved stem loop structures of these precursors have launched the 
development of bioinformatics software which has speeded up discoveries of new miRNAs 
from small RNA library cloning and high-throughput sequencing data (Ambros et al., 2003; 
Lim et al., 2003; Ambros and Lee, 2004; Ruby et al., 2006; Berninger et al., 2008).  
 
2.3.1.2 Intracellular transport and processing of mature miRNA 
 
The pre-miRNA is transported into cytoplasm by the transmembrane protein Exportin 5 for 
further processing by RNAse III endonuclease Dicer (Bohnsack et al., 2004; Zheng and 
Cullen 2004). It processes pre-miRNA to yield mature miRNA duplexes of ~22nt in length 
with 5' monophosphate and a 3' overhang closely resembling processing of siRNA 
molecules (Bernstein et al., 2001; Ketting et al., 2001; Carmell and Hannon 2004). In 
addition to a few AGOs, Dicer is the only identified protein shared by miRNA and siRNA 
pathways and the limited amount of the enzyme subjects it to competition between all 
three main small RNA pathways (Lee et al., 2006, Duchaine et al., 2006). Intracellular 
transport of miRNAs has not been detected in C. elegans and no evidence currently exists 
for mature miRNA amplification. 
 
2.3.1.3 Target mRNA association 
 
At least two AGOs, ALG-1 and ALG-2, have been identified to associate with Dicer and to 
recruit mature miRNAs to their RNAi effector complexes, also referred to as miRISC or 
miRNP (Grishok et al., 2001; Yigit et al., 2006). miRNAs associate with the effector 
complex to mediate inhibition of translation via imperfect hybridization with the target 
mRNA (Lim et al., 2003; Ambros et al., 2003). Hybridization with mismatches has been 
shown to lead to problems in initiation of translation instead of triggering mRNA 
degradation, but details of this process remain to be elucidated (Olsen and Ambros, 1999; 
Pillai et al., 2005; Nissan and Parker 2008). In vitro experiments using mammalian cells 
have led to the suggestion that effector complex enzymes may interfere with the ability of 
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the m7G-cap structures at the 5’ end of the mRNA to recruit the translation initiation 
complex (Wang et al. 2006; Mahonnet et al., 2007). 
 
2.3.1.4 miRNAs function as developmental regulators in C. elegans 
 
In C. elegans, with a relatively short life cycle and efficient reproduction, numerous findings 
point towards the role of miRNAs in worm development. During transition from one larval 
stage to the next, miRNAs regulate the expression of heterochronic genes with 
inappropriate function in a strictly timed and orchestrated manner (Ambros et al., 2003; 
Pasquinelli and Ruvkun 2002; Stoeckius et al., 2009). For example, by regulating 
heterochronic genes such as lin-28 and lin-41, the let-7 family members, let-7 and miR-84, 
regulate moulting by controlling stem cell-like seam cell lineage division and cuticle 
formation during transition from fourth larval stage (L4) to adult stage while miR-48, miR-
84 and miR-241 regulate transition from L2 to L3 stage (Abbot et al., 2005; Abrahante et 
al., 2003). As human lin-28 and lin-41 orthologs are key mediators of stem cell self 
renewal and are associated with tumor growth in various cancers (Lu et al., 2005), the let-
7 family is perhaps the most intensely studied miRNA family in C. elegans.  
         Furthermore, miRNAs are required for neuronal development and synaptic function 
in C. elegans. miR-1, a conserved muscle-specific miRNA, has been shown to regulate the 
efficiency of signalling at C. elegans neuromuscular junctions by regulating the expression 
of nicotinic acetylcholine receptor (nAChR) subunits UNC-29 and UNC-63, and the 
transcription factor MEF-2 (Simon et al., 2008). In addition, left/right asymmetry of 
chemosensory taste receptor expression is shown to be controlled in morphologically 
bilateral neurons ASE left (ASEL) and ASE right (ASER) by miRNA lsy-6 (Johnston and 
Hobert, 2003). In the future, additional neuronal processes involved with miRNA-mediated 
gene regulation in C. elegans will certainly be uncovered. 
 
2.3.2 Endogenous siRNAs 
 
Recent cloning and high-throughput sequencing efforts have shown that up to thousands 
of candidate endo-siRNAs are transcribed from the genome of C. elegans (Ambros et al., 
2003; Duchaine et al., 2006; Lee et al., 2006; Ruby et a., 2006; Asikainen et al., 2008). 
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Endo-siRNA sequences match perfectly with the sequences of their target mRNAs which 
helps to identify their candidate target genes. As in plants, Dicer produced primary siRNAs 
are amplified by RdRP and its co-factors to yield a bulk of secondary siRNAs (Sijen et al., 
2001; Lee et al., 2006; Pak and Fire, 2007). This is contradictory to siRNA pathways in 
other animals where siRNA amplification, or RdRP activity have not been reported. 
Although only a few common enzymes contribute to miRNA and siRNA pathways, the 
courses of pathways are rather similar (Ambros et al., 2003; Lim et al., 2003; Kim, 2005). 
A simplified model of the endo-siRNA pathway is shown in Figure 2. 
 
2.3.2.1 Precursor molecules 
 
The structure of the endo-siRNA precursor transcribed from the genome remains to be 
identified. Several models for "aberrant" dsRNA precursor have been proposed based on 
observations in plants, D. melanogaster, and mice. As primary endo-siRNAs are 
apparently derived from exonic sequences they could be processed from side products of 
alternative splicing. Alternatively, their cognate transcripts may be dedicated uniquely for 
siRNA synthesis. Additional models suggest that endo-siRNA precursors are transcribed 
bidirectionally to form dsRNA, or the single stranded (ss) RNA with inverted repeat 
sequences that could form a “hairpin-loop” dsRNA precursor (Duchaine et al., 2006; Lee et 
al., 2006; Okamura and Lai, 2008). However, endo-siRNA precursors have not yet been 
unambiguously identified. 
 
2.3.2.2 Transport through cellular membranes 
 
It remains to be demonstrated if endo-siRNAs are subjected to intercellular transport in C. 
elegans. However, the precursor RNA is likely transported from the nucleus into the 
cytoplasm, and mature endo-siRNAs from the cytoplasm into the nucleus, for example by 
the AGO protein NRDE-3, similar to exo-siRNAs (Guang et al., 2008).  
 
2.3.2.3 Dicer 
 
The type III endoribonuclease protein Dicer (DCR-1), with dsRNA binding motifs 
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(dsRBMs), ribonuclease III (RNAse III) domains and a DExH-box RNA helicase motif, 
slices the RNA precursor into small RNA duplexes of ~21 base pairs (bp) in length with 5' 
monophosphate and protruding 3' ends, often referred to as primary siRNAs (Figure 2; 
Bernstein et al., 2001; Elbashir et al., 2001; Ketting et al., 2001; Grishok et al., 2001; 
Duchaine et al., 2006). Dicer co-precipitates with a number of proteins and the 
involvement of Dicer in parallel small RNA pathways makes the study of its associated 
proteins and their molecular function challenging (Duchaine et al., 2006). Because C. 
elegans contains only one Dicer gene, different small RNA pathways compete with it 
suggesting maintenance of a delicate balance between different silencing pathways 
(Duchaine et al., 2006). 
 
2.3.2.4 Argonautes 
 
Argonautes (AGOs) are small RNA-specific binding proteins thought to act as guides for 
different species of small RNAs to direct their functions towards specific cellular or 
developmental processes (Yigit et al., 2006). Most of C. elegans 27 AGO proteins have 
been discovered only recently and have been implicated in functions of siRNA pathways, 
many possibly involved in the “laborious” process of secondary siRNA synthesis. AGOs 
contain two key domains, PAZ and RNAse H related PIWI, that facilitates binding to 3’ and 
5’ termini of  small RNA (respectively) leaving internal nucleotides available for base-
pairing with the target mRNA. Molecular variations exist in PAZ and PIWI domains 
suggesting qualitatively distinct activities for specific AGOs. In siRNA pathways, AGOs can 
be divided as upstream AGOs and downstream AGOs depending on their specificity for 
Dicer processed primary or RdRP-processed secondary siRNAs (Figure 2, Table 1). For 
example, conserved metal coordinating residues in the PIWI domain may direct substrate 
specificity towards binding to secondary siRNAs (Yigit et al., 2006).  
          At least three AGOs have been shown to be involved in the endo-siRNA pathway 
(Yigit et al., 2006). Similarity in sequence domains with the well studied exo-siRNA 
pathway-specific RDE-4, suggests that ERGO-1 recruits endo-siRNAs from Dicer to the 
RNAi effector complex. Recently identified downstream AGOs, SAGO-1 and SAGO-2, are 
thought to recruit secondary endo- and exo-siRNAs into proximity of the target mRNA. By 
sharing these two AGOs, endo-siRNA and exo-siRNA pathways would converge for 
competition (Figure 2; Duchaine et al, 2006; Yigit et al., 2006). CSR-1 was recently 
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reported as a candidate for mRNA slicing activity (Aoki et al., 2007). 
 
2.3.2.5 RNA-dependent RNA polymerase 
 
RNA-dependent RNA polymerases (RdRPs) are required for efficient gene silencing in C. 
elegans (Sijen et al., 2001). From four RdRP protein paralogs in C. elegans, the protein 
RRF-3 is thought to mediate synthesis of secondary endo-siRNAs. According to the 
current model based on genetic analysis on C. elegans, exo-siRNA-specific RRF-1 (see 
chapter 2.3.3.5), RRF-3 may slide on the target mRNA template and determine the place 
of initiation for secondary siRNA synthesis using the primary endo-siRNA as a guide 
molecule (Sijen et al., 2001; Lee et al., 2006; Pak and Fire, 2007). Sequence analysis 
suggests that C. elegans RdRPs are able to initiate RNA synthesis de novo in a primer 
independent manner (Makeyev and Bamford, 2002; Salgado et al., 2006).  
          RRF-3 co-precipitates with Dicer and ERI-1 which is a conserved protein with 
DEDDh-like exonuclease and SAP/SAF-box nucleic acid binding domains (Kennedy et al., 
2004; Duchaine et al., 2006). While the precise function of ERI-1 remains unknown, it has 
been suggested that it could modify the structure of the mRNA template suitable for RRF-3 
mediated siRNA synthesis, or may shape RRF-3 products to yield mature secondary 
siRNAs (Duchaine et al., 2006; Asikainen et al., 2007).  
 
2.3.2.6 Target mRNA association 
 
The siRNA guided ribonucleoprotein complex that is able to associate and degrade target 
mRNA is collectively called the RNAi effector complex, RNAi Silencing Complex (RISC), or 
siRNA- specific ribonucleoprotein (siRNP) complex (Gu et al., 2007). Although no 
biochemical interaction or coprecipitation studies have been performed, there exists 
genetic evidence that the endo-siRNA pathway-specific RNAi effector complex may 
contain ERGO-1, SAGO-1, SAGO-2 and CSR-1 (Yigit et al., 2006; Aoki et al., 2007).  
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2.3.2.7 Endo-siRNAs may control protein phosphorylation, development and sperm 
function in C. elegans 
 
Numerous endo-siRNAs are thought to maintain continuous silencing of endogenous 
genes in C. elegans by inducing the degradation of their target mRNAs (Duchaine et al., 
2006; Lee et al., 2006). Detailed analysis of the target genes is required to understand the 
biological role of the pathway. One of the first identified genes targeted by an endo-siRNA 
was K02E2.6, which encodes a protein resembling retroviral aspartyl proteases (Duchaine 
et al., 2006). In addition, we have identified a pool of endo-siRNA target candidates by 
microarray analysis of C. elegans rrf-3 and eri-1 mutants suggesting that the role for at 
least some endo-siRNAs, is in regulating protein phosphorylation and sperm motility 
(Asikainen et al., 2007). Furthermore, we annotated and functionally characterized a pool 
of candidate endo-siRNA sequences obtained from high-throughput sequencing projects 
providing additional evidence that protein phosphorylation and development associated 
genes are regulated by the pathway (Asikainen et al., 2008). 
 
2.3.3 siRNAs derived from exogenous agents 
 
The report by Fire, Mello and co-workers, that efficient gene silencing can be triggered by 
delivering the exogenous dsRNA into C. elegans, initiated the RNAi research in animal 
models (Fire et al, 2008). After entering into the cytoplasm, the exogenous dsRNA is 
cleaved resulting in a pool of small interfering RNAs (exo-siRNAs) able to hybridize with 
mRNA containing the corresponding sequence, leading to inhibition of the respective gene 
function via mRNA degradation. More recently, some studies with the exogenous 
precursor dsRNA have suggested that exo-siRNAs may trigger heterochromatin formation 
in corresponding sequences in the nucleus, while studies on the actual mechanism have 
not yet been published (Grishok et al., 2005; Robert et al., 2005; Guang et al., 2008; 
Meister, 2008). C. elegans with defects in the exo-siRNA pathway are particularly sensitive 
to infection by RNA viruses, suggesting a still existing antiviral role for this particular 
pathway (Wilkins et al., 2005; Schott et al., 2005). Contrary to siRNA pathways in other 
animals, or to the miRNA pathway, the gene silencing by the exo-siRNA pathway is able to 
spread through the worm body. The RdRP-mediated siRNA amplification (Figure 2, 
2.3.3.5) along with putative siRNA-specific transporters could explain the ability. A 
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simplified model of the exo-siRNA pathway is shown in Figure 2. 
 
2.3.3.1 Precursor molecules 
 
Cellular invasion of exogenous dsRNA of virtually any length, from a few dozen bp to more 
than 1000 bp, can trigger efficient silencing of homologous gene sequences in C. elegans 
(Fire et al., 1998; Timmons et al, 2001; Parker et al., 2008). In the laboratory, efficient 
gene silencing can be triggered by injection of in vitro transcribed dsRNA into any position 
of the worm body (Fire et al., 1998), by soaking them in solution containing dsRNA 
(Tabara et al., 1998), or feeding them with transformed bacteria producing dsRNA with the 
sequence corresponding to the gene targeted (Timmons et al., 2001; Kamath et al., 2001). 
dsRNA can also be introduced via transgenes (Kim et al., 2005) but its entry into the exo-
siRNA or corresponding pathway is not evident. In primitive eukaryotes, the invasion of 
dsRNA genomes of RNA viruses probably triggered the evolution of the protective exo-
siRNA pathway (Obbard et al., 2009; Cerutti et al., 2006; Shabalina and Kooning, 2008). 
 
2.3.3.2 Transport through cellular membranes 
 
dsRNA is transported into the cytoplasm throughout the worm body by cell membrane 
transport proteins SID-1 (systemic RNAi deficient) and SID-2 (Winston et al., 2002; 
Feinberg and Hunter 2003; Winston et al., 2007). When SID-1 is expressed in cell 
membranes of virtually all non-neuronal cells including germline, SID-2 is expressed only 
in the intestinal lumen aiding in the efficient uptake of ingested dsRNA. Indeed, injection of 
dsRNA into the intestine triggers the most efficient gene silencing effect in C. elegans 
(Kamath et al., 2001; Asikainen et al., 2005). Transport of dsRNA into germline cells 
facilitates inheritability of the gene silencing effect up to 60 generations (Fire et al., 1998; 
Vastenhouw et al., 2006). SID-1 is conserved also in mammals including human (Duxbury 
et al., 2005). Recently, the protein NRDE-3 was identified to transport exo-siRNAs from 
the cytoplasm into the nucleus (Guang et al., 2008) suggesting the involvement of siRNAs 
in nuclear mechanisms such as in heterochromatin formation (Grishok et al., 2005). 
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2.3.3.3 Dicer 
 
Dicer processes exo-siRNAs from the long precursor dsRNA and the mechanism is 
described in more detail in section 2.3.2.3. 
 
2.3.3.4 Argonautes 
 
At least five AGOs are shown to be involved with the exo-siRNA pathway (Figure 2). The 
initial step is performed by the upstream AGO protein RDE-4 by binding to the long dsRNA 
precursor in a sequence non-specific manner and recruiting it to Dicer to form a functional 
complex (Tabara et al., 1999; Parrish et al., 2001; Tabara et al., 2002). Another upstream 
AGO, RDE-1 is a conserved protein shown to form a complex with Dicer, RDE-4, and RNA 
helicase DRH-3. It binds to Dicer processed primary exo-siRNAs, dissociates, and 
transports them into proximity of the target mRNA (Tabara et al., 1999; Tabara et al., 
2002; Yigit et al., 2006). It facilitates the interaction of exo-siRNA with targeted mRNA and 
recruits an RdRP to initiate the amplification process of exo-siRNAs. Downstream AGOs, 
SAGO-1 and SAGO-2, interact with secondary exo-siRNAs and endo-siRNAs and may 
recruit them to the proximity of the target mRNA. Upon mRNA target recognition by 
secondary AGOs and exo-siRNA, base-pairing interactions and helix formation are 
predicted to place the target RNA in proximity to the catalytic center of the RNAase H-
related PIWI domain of CSR-1's (Aoki et al., 2007). This interaction is thought to lead 
directly to target mRNA cleavage (Yigit et al., 2006). 
 
2.3.3.5 RNA-dependent RNA polymerase 
 
RRF-1 is able to trigger synthesis of a large number of secondary exo-siRNAs antisense to 
the target mRNA in C. elegans soma. Newly synthesized secondary siRNAs scatter in 
both directions from the primary siRNA binding site reflecting primer independent initiation 
of synthesis for each unique secondary siRNA (Pak and Fire, 2007). RRF-1 products, 
single strand secondary exo-siRNAs, have been shown to bear 5' triphosphorylated ends 
(Pak and Fire, 2007) in contrast to Dicer processed primary exo-siRNAs with a 5' 
monophosphate end (Elbashir et al., 2001).  
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2.3.3.6 Target mRNA association 
 
Recently, exo-siRNA associated proteins likely representing the effector complex of 
molecular weight ~60KDa were eluted in a chromatographic procedure, which suggests 
that the endo-siRNA-specific effector complex might be rather small and contain only a few 
proteins (Gu et al,. 2007). However, many candidate proteins in siRNA/target mRNA 
association such as RDE-1, SAGO-1, SAGO-2 and CSR-1 have been identified, which 
suggests that the complex might actually be much larger (Ambros et al, 2003; Lim et al., 
2003; Yigit et al., 2006). Similar to the endo-siRNA pathway, perfect hybridization without 
any mismatches with a target mRNA is thought to lead to its degradation by CSR-1 (Aoki 
et al., 2007).  
 
2.3.3.7 Exo-siRNAs mediate specific silencing of any gene with the corresponding 
sequence 
 
The destruction of threatening viral genomes is considered to hold the primary role of exo-
siRNA pathway in C. elegans as no other roles have been suggested so far (Ding et al., 
2007; Obbard et al., 2009). Because the dsRNA precursor is transported virtually into all 
cells including the germline, the viral defence is inherited for the progeny (Fire et al., 1998; 
Vastenhouw et al., 2006). Interestingly, some studies have provided evidence that the exo-
siRNA pathway can inhibit gene expression by epigenetic mechanisms. In fission yeast, 
Schizosaccharomyces pombe (S. pombe), the siRNA pathway mediates heterochromatin 
formation by recruitment of the histone H3 lysine 9 methyltransferases such as Clr4 and 
ClrC (Volpe et al., 2002; Motamedi et al., 2004; Djupedal and Ekwall, 2009). The 
laboratory of Scott Kennedy was able to discover a C. elegans AGO able to transport 
cytoplasmic siRNAs into the nucleus (Guang et al., 2008). In addition, Alla Grishok and co-
workers observed heterochromatin formation in transgenic sequences after feeding C. 
elegans with dsRNA. Furthermore, the gene silencing effect can be maintained as long as 
tens of generations from dsRNA delivery indicating the permanent nature of responses in 
target cells (Vastenhow et al., 2006). These findings strongly suggest that the cytoplasmic 
gene silencing process can be further sustained in the nucleus, for example, by the 
heterochromatin formation in C. elegans.  
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2.3.4 Piwi-interacting RNAs (21U-RNAs) 
 
In addition to miRNAs and endo-siRNAs, cloning studies have revealed approximately 
16500 new endogenous germ cell-specific small RNAs in C. elegans termed as piRNAs 
(Ruby et al., 2006; Batista et al., 2008). Before finding the phylogenetic association with 
mammalian piRNAs, the species were called 21U-RNAs because they were exactly 21 
nucleotides in length and exhibited an urasil base in their 5’ termini (Ruby et al., 2006). 
Few studies have been performed concerning their functions and roles and they are 
thought to provide essential germline functions such as maintaining genome integrity and 
fertility (Batista et al., 2008) with mechanisms resembling mammalian piRNAs (Carmell et 
al., 2007; Aravin et al., 2007). 
 
2.3.4.1 Origin of the precursor RNAs 
 
Virtually all C. elegans piRNAs are autonomously transcribed from two large clusters in 
chromosome 4 (Ruby et al., 2006). The molecular characteristics of precursors remain 
unknown. 
 
2.3.4.2 piRNA biosynthesis 
 
No evidence currently exists to support the notion that C. elegans piRNAs are transported 
into the cytoplasm as miRNAs or siRNAs. Furthermore, they fail to exhibit complementarity 
with any mRNAs (Ruby et al., 2006; Batista et al., 2008) and there is no demonstration for 
a role of Dicer in processing of piRNAs (Aravin et al., 2007; Houwing et al., 2007). 
 
2.3.4.3 piRNAs may control germline genome integrity 
 
There exists evidence that piRNAs may be involved in germline genome integrity, sperm 
function and transposon control in C. elegans such as in mammals (Carmell et al., 2007; 
Aravin et al., 2007; Houwing et al.,2007) , but the mechanism remains to be elucidated. 
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2.4 Involvement of microRNAs in neurodegenerative diseases 
 
In addition to the significance of miRNAs in regulation of cell differentiation, there are 
studies that support a role for their involvement in regulating physiology of differentiated 
cells. For example, studies have suggested a link between miRNA pathways and 
neurodegenerative diseases. Inducible, neuron type-specific Dicer knock-out mice studies 
have shown an essential role of miRNAs in mature neuron survival since knocking-out 
Dicer in dopaminergic or cerebellar neurons induces a slow neurodegeneration. Moreover, 
dopamine neuron-specific human miR-133b has been shown to regulate maturation and 
function of midbrain dopaminergic neurons. Indeed, miR-133b is downregulated in patients 
of Parkinson’s disease (Kim et al, 2007; Schaefer et al., 2007). Furthermore, a large 
genetic analysis of single-nucleotide polymorphisms revealed that a variation in the 
binding site of miR-433 on fibroblast growth factor FGF20 mRNA confers risk for PD by 
over-expression of α-synuclein (Wang et al., 2008). Keeping in mind that the miRNA-
target-interaction research is a relatively new field of science, it is likely that tens or 
hundreds of miRNAs essential for neuron survival await discovery. 
 
2.4.1 Prospects in microRNA-therapy 
 
The ability of miRNAs to regulate the expression of hundreds of genes via silencing 
transcription factors and other regulators (Lim et al., 2005; Makeyev and Maniatis, 2008) 
make miRNAs important factors for maintaining proper cell function and physiology. Thus, 
identification of differentially regulated miRNAs during the process of neurodegeneration 
could reveal important drug targets, and in theory, successful manipulation of miRNA 
expression could re-regulate gene expression towards a healthier state. Short hairpin 
RNAs (shRNAs), mammalian counterparts of exo-siRNAs, have been reported to induce 
toxic effects via the interferon pathway in mammalian cells, especially in brain (McBride et 
al., 2008). However, when delivering synthetic miRNAs or modified shRNAs implementing 
features of naturally occurring miRNAs, toxic effects were attenuated (McBride et al., 
2008; Bauer et al., 2009). Thus, miRNA-based approaches may provide more appropriate 
biological tools for gene inhibition. 
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3 AIMS OF THE STUDY 
 
The general aim was to study effectiveness, functions, and relationships between 
exogenous and endogenous small RNA-mediated gene regulation pathways in order to 
provide a more thorough understanding of their biology with the prospect of using this 
information for development of small RNA-based therapeutic tools for neurodegenerative 
and other diseases. For these purposes, the following tasks were performed: 
 
 
1) The effectiveness of exo-siRNAs in different neuron types was measured      
(Publication I). 
 
2) The biological functions of endo-siRNAs were studied (Publications II-III). 
 
3) The involvement of microRNAs in molecular mechanisms associated in pathology of 
Parkinson’s disease was studied (Publication IV). 
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4 MATERIALS AND METHODS 
 
4.1 Worm strains 
 
To be able to visually measure the effectiveness of exo-siRNA precursor dsRNA to silence 
a neuronally expressed transgene, seven C. elegans strains, each expressing Green 
Fluorescent Protein (GFP) under different neuron type-specific promoters, were obtained 
(Publication 1, Table 2). To study the possible sensitizing effect of dysfunctional RRF-3 
enzyme, each strain was further crossed into rrf-3 -/- (pk1426) loss of function mutant 
strain NL2099 (Sijen et al., 2001), to obtain seven additional strains with loss of RRF-3 
enzyme activity.  
 
 
Table 2. Seven gfp-transgenic worm strains used to measure effectiveness of exo-siRNAs 
to silence a neuronal transgene. Strain AZ217 was used as a non-neuronal control.     
Transgenic worm strains 
Name Genotype Phenotype Reference 
SA1002 aex-3::gfp GFP in all neurons Lakso et al., 2003 
EG1285 unc-47::gfp GFP in GABAergic neurons Mc Intire et al., 1997 
SA1003 dat-1::gfp GFP in dopaminergic neurons Nass et al., 2002 
SA1001 acr-2::gfp GFP in cholinergic neurons Hallam et al.,2000 
SK4005 mec-4::gfp GFP in touch neurons Lai et al., 1996 
DA1240 eat-4::gfp GFP in glutamatergic neurons Lee et al., 1999 
AZ217 myo-2::gfp GFP in pharynx muscle Praitis et al., 2001 
   
 
4.2 dsRNA administration and analysis of phenotypes 
 
The precursor dsRNA was delivered by injection-, feeding- and soaking-based methods 
described in Publication I to induce exo-siRNA production and gene silencing in each C. 
elegans strain shown in Table 2. Strains were further crossed with rrf-3 as described 
resulting in fourteen strains for examination. 30 F1 progeny larvae were analyzed at the L4 
stage using fluorescent microscopy under the UV-device as described. A worm was 
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scored as RNAi-sensitive if one or more of its GFP tagged neurons were not detectable or 
were barely detectable. Micrographs were taken from all treated strains to further 
demonstrate the level of silencing. 
 
4.3 Affymetrix microarray hybridizations and data-analysis  
 
The expression analysis was performed for worms with loss-of-function mutant enzymes 
unable to amplify endo-siRNAs to study the process and candidate targets of the endo-
siRNA pathway. Rrf-3 -/- (pk1426) (Sijen et al., 2001), eri-1 -/- (mg366) (Kennedy et al., 
2004) and wild type N2 worm strains were cultivated and synchronized to obtain larval 
stage four (L4) progeny for total RNA isolations. Protocols are described in Publication II. 
The RNA was hybridized on GeneChip® C. elegans Genome Arrays in Biomedicum 
Biochip Center (Helsinki, Finland) by using the manufacturer's protocol (Affymetrix). Arrays 
were prepared for each strain from three independent biological replicate samples. N2 was 
used as a reference when calculating changes in mRNA expression levels in rrf-3 or eri-1. 
For data processing and primary analysis, GeneSpring 7.3-software was used to perform 
data-analysis for CEL-format intensity signals generated by the scanner. Robust Multichip 
Average (RMA)-algorithm was used for normalization and statistical processing. T-tests 
were used to filter out genes with unreliable signal between replicates (p<0.05) and to 
collect genes with significant signal differences between samples (p<0.05, Bonferroni 
correction, False Discovery Rate). Finally, genes showing significant expression change 
two-fold up or down between rrf-3 versus wild type and eri-1 versus wild type were 
collected.  
 
4.4 Quantitative Real-Time PCR and Northern blot  
 
In order to confirm results from microarray analysis, quantitative Real Time-PCR (qRT-
PCR) was performed as described in Publication II. In brief, ABI Prism® 7700 (Applied 
Biosystems)-Real Time PCR-device with Sequence Detection System (SDS) 1.7-software 
were used to obtain CT values for genes ssp-16 (T27A3.3), T16G12.7, C35E7.9, F25B3.4, 
clec-69 (F56D6.15) and an endogenous control gene act-1 as described in Publication II. 
Comparative CT-method with relative quantification (Schmittgen and Livak, 2008) was 
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used to calculate differences in expression levels for rrf-3 and eri-1 when compared to wild 
type. Furthermore, to confirm expression change of gene ssp-16 in rrf-3 and eri-1 versus 
wild type, Northern blot antisense probes for act-1 and ssp-16 were labelled with α-[33P]-
dATP and hybridized to filters containing 10µg of total RNA per lane. 
 
4.5 In silico search for endo-siRNA targets 
 
A total of 7136 candidate endo-siRNA sequences, initially derived from mixed stage C. 
elegans populations by high throughput sequencing technologies (Margulies et al., 2005), 
were obtained from previously published studies (Lee et al., 2006; Ruby et al., 2006). As 
described in Publication III, siRNA sequences were sorted by their lengths and analyzed 
for their nucleotide frequencies using WebLogo (Univ. of Berkeley, CA, USA). In addition, 
due to the property of endo-siRNAs to hybridize perfectly with the mRNAs of their target 
genes, NCBI RefSeq mRNA database was used to collect their antisense mRNAs. 
Annotations and enriched functional categories for corresponding genes were obtained 
using David 2.0 (Dennis et al., 2003) and Biomart databases (Durinck et al., 2005), and 
SPSS (SPSS Inc.) was used in the graphical presentation of the results. 
 
4.6 MicroRNA microarray analysis and qRT-PCR 
 
Human α-synuclein A53T transgenic (asyn tg) C. elegans strain, and loss-of-function 
mutant strains for human VMAT (vesicular catecholamine transporter) paralog (cat-1 -/-) 
and human Parkin paralog (pdr-1 -/-), were used to characterize candidate miRNAs 
associated with molecular mechanisms in pathology of Parkinson’s disease (Publication 
IV, Table 3). These particular C. elegans Parkinson’s disease (PD) models were chosen 
for miRNA expression analysis for the following reasons: α-syn tg strain had a strong 
uncoordinated behaviour and has previously been shown to develop dopaminergic 
neuronal loss (Lakso et al., 2003). cat-1 has been reported to exhibit inability to sense food 
reflecting defective dopaminergic signalling (Duerr et al., 1999). pdr-1 strain was chosen 
because mutations in human Parkin gene causes elevated risk to develop PD. 
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Table 3. C. elegans models of Parkinson’s disease used to study involvement of microRNAs 
in mechanisms of disease pathology. 
Mutant worm strains 
Name Genotype Phenotype Reference 
ls10 α-syn tg uncoordinated movement Lakso et al., 2003 
CB1111 cat-1 -/- unable to sense food Sulston et al., 1975 
VC1024 pdr-1 -/- no observable phenotypes  Springer et al., 2005 
 
 
          Worms were cultivated and harvested, and small RNA was isolated and processed, 
as described in Publication IV. Shortly, small RNA from wild type was labelled with Alexa 
Fluor® 3 dye and RNA from strain of investigation (cat-1, pdr-1, or α-syn) with Alexa 
Fluor® 5 dye. Labeled RNA from the strain of investigation was co-hybridized with labeled 
RNA from wild-type on NCodeTM Multi-Species miRNA Microarray V2-arrays (Invitrogen) 
containing probes for all 115 C. elegans annotated miRNAs in miRBase. Arrays were 
scanned using ScanArray 5000 (GSI Lumonics) and ScanArray Express (Perkin Elmer)-
software generating two colour signal intensity images. Microarray images were converted 
to digital form using TIGR Spotfinder- software (Saeed et al., 2003) and further analyzed 
using Microsoft Office Excel-software (Microsoft). Mean centering was used to normalize 
signal values between channels and fold change in expression was obtained for each 
miRNA by dividing the normalized intensity signal from the strain of investigation with 
normalized intensity signal from the wild type. At least 1.4 fold differentially expressed 
miRNAs were collected from the set of miRNAs with sufficient p-values (<0.05). 
          NCodeTM miRNA First-Strand cDNA Synthesis and qRT-PCR Kits (Invitrogen) were 
used to confirm expression changes of miR-58, miR-64 and miR-65 in the above 
mentioned strains using ABI Prism 7700 and SDS-software (Applied Biosystems) as 
described in Publication IV. 
 
4.7 MicroRNA target query 
 
As described in Publication III, potential targets for differentially regulated miRNAs were 
searched from the literature, and by using the miRBase Targets Database by Score-value 
created by the miRanda algorithm (Griffiths-Jones et al., 2008). 
39 
 
5 RESULTS  
 
5.1 Neuron types exhibit differences in their sensitivity to exo-siRNA 
pathway mediated RNAi  
 
Since neurons exhibit exceptionally strong resistance for exo-siRNA pathway (Kamath et 
al., 2001; Simmer et al., 2003) mediated RNAi, it prompted us to perform measurements 
on their sensitivity by focusing on specific neuron types distinguished by the 
neurotransmitter used. This was done using genetically modified C. elegans strains, each 
expressing a gfp-transgene under a unique promoter able to express the GFP in a specific 
neuron type (Publication I, Table 2). When GFP signal in the unique worm neurons was 
examined after exo-siRNA precursor delivery, all examined neuron types were observed to 
show relatively high resistance by maintaining signal in most neurons, in comparison to the 
faint expression in the pharynx muscle. Significant differences in sensitivity among neuron 
types were observed: GABAergic and dopaminergic neurons showed relatively strong 
resistance and cholinergic, glutamatergic or touch neurons turned out to be more 
sensitive. Typically, in individually examined worms, all neurons exhibited a tendency to 
either show no effect at all, or were all affected (all or nothing). Furthermore, differences in 
effectiveness of delivery methods were observed, dsRNA injections affected usually more 
worms than feeding or soaking. 
 
5.2 Loss of function mutation in RNA-dependent RNA polymerase   
RRF-3 sensitizes neurons to the exo-siRNA pathway 
 
A dramatic decrease in exo-siRNA resistance was evoked when worms were crossed with 
the rrf-3 mutant allele (Publication I). This was almost equally observed in all measured 
neuron types. The GFP signal was observed to disappear from cholinergic, glutamatergic 
and touch neurons and from many GABAergic and dopaminergic neurons. However, some 
of the GABAergic and dopaminergic neurons still remained unaffected. 
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5.3 Protein phosphorylation and sperm motility associated genes are 
candidate targets of the endo-siRNA pathway  
 
To study the role and the mechanism of the endo-siRNA pathway, we performed genome 
wide transcriptome analysis on RRF-3 and ERI-1 loss-of-function mutant strains 
(Publication II). In addition to finding differential expression of the pathway-associated 
genes, we expected to reveal elevated expression of mRNAs of candidate target genes. 
We found 72 common transcripts over-expressed and 4 common transcripts under-
expressed in strains. 72 co-over-expressed transcripts were of interest because they likely 
represent a pool of mRNAs released from under control of RRF-3/ERI-1-specific endo-
siRNA pathway. Protein phosphorylation and sperm motility associated genes were highly 
over-represented among over-expressed transcripts suggesting that these processes are 
controlled by the endo-siRNA pathway. 
 
5.4 Lengths of endo-siRNA sequences associate with ontologies of 
their candidate target genes  
 
To further characterize targets of the endo-siRNA pathway, electronic libraries of available 
candidate endo-siRNA sequences provided by David Bartel and Victor Ambros 
laboratories (Ruby et al., 2006; Lee et al., 2006) were obtained and analyzed in silico 
(Publication III). From a total of 7136 sequences, 4024 were found to exhibit antisense 
complementarity to 2344 known mRNA sequences. Candidate endo-siRNAs were 
distributed by their size and the highest peak was observed in oligomers of 22 nt in length 
(22-mer). Furthermore, annotations and enriched functional categories for corresponding 
genes were obtained and different lengths of endo-siRNAs were observed to associate 
with functionally different target genes: 18- to 22-mer siRNAs were found to associate with 
genes involved in embryonic development, 23-mers were found to associate with genes 
involved in post-embryonic development and 24- to 26-mers with genes involved in 
phosphorus metabolism.  
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5.5 Many mRNAs match with multiple endo-siRNA sequences 
 
When examining sequences of mRNAs of candidate target genes, some were able to align 
with numerous siRNA sequences (Publication III). Interestingly, size distribution of endo-
siRNAs with multiple reads revealed a high representation in 26-mers. For example, 
mRNA F55C9.3, encoding a member of an AGO family with yet unknown function, was 
observed to match with 16 candidate endo-siRNAs. 
 
5.6 Two microRNA families are misregulated in C. elegans models of 
Parkinson’s disease 
 
In order to characterize candidate miRNAs associated with mechanisms of pathology of 
PD, their expression levels were measured in C. elegans models of PD (Publication IV, 
Table 3). The number of differentially regulated miRNAs associated with the severity of the 
model phenotype. The family members miR-64 and miR-65 appeared co-under-expressed 
in α-synuclein and cat-1 strains, and members of let-7 family co-under-expressed (except 
miR-241 over-expressed) in α-synuclein and pdr-1 strains. Class H serpentine receptor 
(srh) family of G-protein-coupled receptor genes were identified as an over-represented 
class of target candidates for miR-64 and miR-65. 
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6 DISCUSSION 
 
The starting point for Publication I was from the observation that neuronal cells have been 
shown to exhibit strong resistance against efforts to induce gene silencing by delivering 
the dsRNA precursor of the exo-siRNA pathway (Kamath et al., 2001; Simmer et al., 
2003). Before developing small RNA-based therapies for human diseases, better 
knowledge in the functions and roles of small RNA pathways is essential, as well as 
finding ways to alleviate the resistance mechanisms when designing therapeutic strategies 
for brain diseases (Timmons et al., 2001; Simmer et al., 2003; Harper and Gonzalez-
Alegre, 2008). Several mechanisms may contribute to the neuron-specific resistance. For 
instance, neurons may express specific RNAi suppressors such as plants (Anandalakshmi 
et al., 2000; Sarmiento et al., 2006), express naturally low levels of key pathway enzymes, 
or lose them to competing pathways (Lee et al., 2006). No direct suppressors of RNAi has 
been identified in C. elegans to date, which suggests that neurons simply exhibit low levels 
of key enzymes which are subjected further to competition between diverse small RNA 
pathways. To support this hypothesis, competition between C. elegans small RNA 
pathways has been reported (Duchaine et al., 2006; Lee et al., 2006). In addition, the 
same reasoning could explain neuron type-specific levels in resistance observed in 
Publication I, although no direct evidence for this hypothesis has been reported to date. 
Initially, RRF-3 and ERI-1 were thought to play roles as endogenous suppressors of the 
presently known RNAi pathway, now named as the exo-siRNA pathway (Duchaine et al., 
2006; Lee et al., 2006). Our results, which indicated that loss of RRF-3 enzyme activity 
enhances the sensitivity of neurons to RNAi, were difficult to explain, until the role of RRF-
3 and ERI-1 was revealed in the amplification machinery of the endo-siRNAs (Duchaine et 
al., 2006; Lee et al., 2006). In light of these new findings, the exo-siRNA pathway seems to 
increase in power by benefiting from extra enzymes from the “broken” endo-siRNA 
pathway explaining the elevated sensitivity of neurons, as well as somatic cells (Kamath et 
al., 2001; Simmer et al., 2003), for dsRNA treatments in rrf-3 or eri-1 mutant background. 
In Publication I, the tendency of examined neurons to either show full or no effect 
(described in 5.1), could be explained by the dsRNA to be either able to trigger, or not, the 
siRNA amplification process, which would ensure robust silencing. The ability of the RNAi-
effect to spread would further silence additional neurons. Differences in effectiveness 
between delivery methods could be explained by the level of dsRNA quantities reaching 
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the worm digestive tract-specific transporter SID-2 (Winston et al., 2007). When injected 
directly into the intestine, feeding dsRNA producing bacteria, or soaking worms in dsRNA 
dilution, all will induce the drift of dsRNA into the digestive tract, but apparently with 
different efficacy. Keeping in mind that gene-specific differences have been observed in 
sensitivity for silencing by exo-siRNAs (Kennedy et al., 2003), and that a transgene was 
used in this approach, silencing GFP may not perfectly mimic silencing process of all 
endogenous genes.  
          In Publication II, 72 commonly over-expressed mRNAs observed in rrf-3 and eri-1 
mutant worms provides support for the theory by Duchaine et al., 2006, that RRF-3 and 
ERI-1 co-operate in the endo-siRNA amplification machinery, and provides a list of 
candidate endo-siRNAs for further analysis. Proteins associating with protein 
phosphorylation were highly over-represented in GO terms among co-over-expressed 
mRNAs suggesting that protein phosphorylation is under control of the endo-siRNA 
pathway. In addition, several sperm motility-associated genes were observed as co-over-
expressed suggesting that the sperm defect observed in rrf-3 and eri-1 strains is caused 
by release of certain sperm motility genes from endo-siRNA-mediated gene regulation. 
The link provided between the endo-siRNA pathway and a universal process of protein 
phosphorylation suggests that a range of cellular processes are regulated by endo-
siRNAs.  
          In Publication III, we characterized currently available candidate siRNA sequences 
in order to obtain knowledge on their role in C. elegans. The length distribution of 
candidate endo-siRNAs in sequence libraries (Ruby et al., 2006; Lee et al., 2006) 
suggests that 22-mer siRNAs are the most prevalent endo-siRNA species in C. elegans, 
even though an average siRNA length has been previously proposed to be 21 nt (Ambros 
et al., 2003). In search of endo-siRNA targets, 4024 of siRNAs exhibited antisense 
complementarity to 2344 known mRNA sequences and GO term analysis for these 
indicated that the cognate genes for specific lengths of siRNAs associate with particular 
GO terms. For example, the length of 18-22-mer siRNAs associate with genes associated 
with embryonic development, 23-mer siRNAs associate uniquely with post-embryonic 
development, and 24-26-mer siRNAs with phosphorus metabolism or protein modification. 
These results provide evidence that length of siRNAs is consequential to their biological 
function. There is increasing evidence that certain AGOs bind only specific species of 
small RNA (Yigit et al., 2006; Batista et al., 2008), perhaps by detecting their specific 
length. Thus, pathway-specific AGOs could further direct specific siRNAs towards the 
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“right” cellular processes. The observation that multi-read siRNAs are enriched especially 
in 26-mers could be explained by RdRP-mediated amplification. When combined with the 
observation that the levels of transcripts associating with protein phosphorylation are 
elevated in RRF-3 and ERI-1 mutants, one can hypothesize that 26-mers are products of 
RRF-3/ERI-1-specific endo-siRNA amplification machinery. In discrepancy with the 
microarray analysis of L4 stage rrf-3 and eri-1 mutants (Publication II), the enrichment of 
sperm motility-associated candidate siRNAs was not observed in this study. This might be 
explained by their dilution in a set of small RNAs obtained from a pool of mixed stage C. 
elegans as the sperm production almost uniquely takes place at the L4 stage. As an 
interesting example, transcript F55C9.3, encoding an AGO family member, matched with 
16 unique siRNAs. This provides intriguing evidence that some small RNA binding proteins 
are under control of small RNA mediated gene silencing which suggests even more 
complex cross regulatory processes between small RNA pathways than previously 
thought. Unfortunately, F55C9.3 has not yet been linked with any specific small RNA 
pathway (Yigit et al., 2006).  
         In order to characterize candidate miRNAs involved in mechanisms of pathology of 
human PD, expression levels of all presently annotated miRNAs were measured in three 
C. elegans models of PD: α-syn tg, cat-1 and pdr-1 (Publication IV.). The largest amount of 
differentially expressed miRNAs were observed in C. elegans expressing human α-
synuclein A53T transgene (α-syn tg)  which exhibits a strong uncoordinated phenotype 
and the loss of dopaminergic neurons (Lakso et al., 2003). The mutated form of the protein 
α-synuclein exhibits the amino acid tyrosine replacing alanine in amino acid position 53 
(A53T) and families carrying the allele have a high tendency to develop early onset 
Parkinson’s disease (Farrer et al., 1999). In a functional form, α -synuclein is thought to 
regulate DA transmission and the dynamics of synaptic vesicles, but when mutated, 
accumulates to form intracellular proteinaceus inclusions called Lewy bodies (LBs), the 
hallmark of Parkinson’s disease (Polymeropoulos et al., 1997; Farrer et al., 1999; 
Singleton et al., 2003). The human VMAT gene ortholog cat-1 mutant in C. elegans has 
been shown to be unable to transport DA into synaptic terminals of neurons and thus 
cannot sense the presence of food. In search of putative targets of miR-64 and miR-65, 
which were observed as under-expressed in α-syn tg and cat-1 strains, over-
representation of chemosensory receptors of Class H were found (Robertson 2000). 
According to our hypothesis, defective dopaminergic system in these worm models could 
induce the loss of dopaminergic G-protein-coupled receptor expression. If miR-64 and 
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miR-65 would have a role in inhibition of G-protein coupled receptor expression, defective 
or dying cells could benefit from down-regulation of miR-64 or miR-65 and further up-
regulation of G-protein coupled receptors.  
          The strain pdr-1, with a deletion mutation in a human Parkin ortholog, was included 
into the experiment as mutations in the human Parkin gene leads to high risk in developing 
Parkinson's disease. About half of the individuals with the mutation develop onset of PD at 
an age of <25 years (Mata et al., 2004). As an E3 ubiquitin protein ligase, Parkin is 
postulated to play a protective role in proteasomal degradation of damaged and unwanted 
proteins (Kitada et al., 1998; Shimura 2000; Mata et al., 2004). Only a few differentially 
expressed miRNAs were found in the pdr-1 mutant which has no observable phenotype. 
Specific members of the let-7 family of miRNAs were observed as differentially expressed 
in pdr-1 and α-syn tg strains. Biochemical investigation of targets of the let-7 family 
suggests that they control the timing of moulting by fate specification of hypodermal cells 
via inhibiting lin-28, lin-41 and hbl-1 activity (Abbot et al., 2005). Interestingly, the target 
gene hbl-1 is widely expressed in neurons, but its neuronal functions remains to be 
elucidated (Lin et al., 2003; Hayes et al., 2006; Sempere et al., 2004). Thus, the differential 
expression of let-7 family of proteins in PD model strains is yet difficult to explain. 
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7 SUMMARY 
 
The aim of this study was to gain knowledge in the effectiveness, functions, and 
complexity of cross-talking small RNA mediated gene regulation pathways using the model 
organism C. elegans with the prospect of developing small RNA-based therapies for 
human diseases. To summarize the main findings: 
 
1) The effectiveness of exogenously induced small RNA-treatments was observed to vary 
when silencing a transgene in different, specific neuron types, and dysfunctional RRF-3 
enzyme was found to sensitize all neuron types for treatments. This information provides 
prospects for further studies concerning the development of exo-siRNA-based therapies 
for neuron type-specific diseases. 
 
2) Complex relationships between siRNA pathways and their involvement in a diverse 
range of physiological processes such as in protein phosphorylation, sperm motility and 
larval development were discovered. The finding cautions that attempts to manipulate one 
siRNA pathway may cause unexpected outcomes in its interacting pathways. 
 
3) In C. elegans models of Parkinson’s disease, specific families of differentially regulated 
miRNAs were observed. The finding links miRNA-mediated gene regulation with pathways 
involved in maintaining dopaminergic neuron survival. 
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